文献速递生殖医学

供精与配偶精行IVF周期的早期妊娠结局:基于人类受精与胚胎学管理局(1991-2016年)记录的1 376 454个周期的分析

Early pregnancy outcomes of IVF cycles using donor versus partner sperm: analysis of 1 376 454 cycles recorded by the Human Fertilisation and Embryology Authority (1991-2016).
PubMed 文献 · Hum Reprod · 2023-01-01

该回顾性队列研究分析人类受精与胚胎学管理局1991至2016年登记的1 376 454个IVF周期,比较供精与配偶精受孕的早期妊娠结局。供精组生化妊娠、流产和异位妊娠的调整比值比均低于配偶精组,未发现不良妊娠结局风险增加。

要点

  • 供精受孕者生化妊娠风险低于配偶精受孕者(aOR 0.82,95%CI 0.78-0.86)。
  • 供精受孕者流产风险低于配偶精受孕者(aOR 0.93,95%CI 0.89-0.97)。
  • 供精受孕者异位妊娠风险低于配偶精受孕者(aOR 0.77,95%CI 0.66-0.90)。

核心结论

  • 供精受孕的妊娠早期流产和异位妊娠的比值比低于配偶精受孕者。
  • 供精受孕未增加不良妊娠结局风险。
  • 作者认为供精受孕者流产减少提示精子可能在流产中起作用,因为供精者筛选过程严格。

研究设计与样本

  • 回顾性队列研究,分析人类受精与胚胎学管理局登记库1991至2016年的1 376 454个使用供精或配偶精的周期。
  • 排除包含宫内人工授精、供卵、植入前遗传学检测、卵子复苏周期及其他替代生育治疗的周期。
  • 采用逻辑回归调整女方年龄、不孕原因、既往妊娠史、新鲜或冷冻周期、IVF或ICSI、移植胚胎数和治疗年份等混杂因素。

主要发现

  • 供精受孕者生化妊娠的aOR为0.82(95%CI 0.78-0.86),低于配偶精受孕者。
  • 供精受孕者流产的aOR为0.93(95%CI 0.89-0.97),低于配偶精受孕者。
  • 供精受孕者异位妊娠的aOR为0.77(95%CI 0.66-0.90),低于配偶精受孕者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 本研究为回顾性研究,受常规收集数据的限制。
  • 缺乏母亲BMI、吸烟和伴侣年龄等可能混杂因素的数据。
  • 数据仅按周期水平报告且无母亲标识,无法考虑同一女性多次妊娠的聚类效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are the early pregnancy outcomes of IVF pregnancies conceived with donor sperm different to those conceived with partner sperm? SUMMARY ANSWER: Pregnancies conceived with donor sperm have a lower odds of early pregnancy loss and ectopic pregnancy compared to pregnancies conceived with partner sperm. WHAT IS KNOWN ALREADY: The number of cycles using donor sperm has risen significantly in recent years. Adverse early pregnancy outcomes have a negative impact on women and their partners. The evidence available to date regarding early pregnancy outcomes for pregnancies conceived with IVF donor sperm is limited by low numbers and lower-quality studies. STUDY DESIGN, SIZE, DURATION: This is a retrospective cohort study of 1 376 454 cycles conceived with either donor or partner sperm between 1991 and 2016 as recorded in the Human Fertilisation and Embryology Authority (HFEA) Register. PARTICIPANTS/MATERIALS, SETTING, METHODS: The HFEA has recorded data on all fertility treatments carried out in the UK from 1991 onwards, and it publishes this data in an anonymized form. This study assessed the outcomes of all pregnancies conceived with donor sperm and compared them to those conceived with partner sperm among IVF cycles recorded in the HFEA anonymized dataset from 1991 to 2016. Cycles that included intrauterine insemination, donor oocytes, preimplantation genetic testing, oocyte thaw cycles and alternative fertility treatments were excluded. The outcomes of interest were biochemical pregnancy, miscarriage, ectopic pregnancy, stillbirth and live birth. Logistic regression was used to adjust for confounding factors including age of the female partner, cause of infertility, history of previous pregnancy, fresh or frozen cycle, IVF or ICSI, number of embryos transferred, and year of treatment. Results are reported as adjusted odds ratios (aOR) and 95% CIs. MAIN RESULTS AND THE ROLE OF CHANCE: This study found reductions in the odds of biochemical pregnancy (aOR 0.82, 95% CI 0.78-0.86), miscarriage (aOR 0.93, 95% CI 0.89-0.97), and ectopic pregnancy (aOR 0.77, 95% CI 0.66-0.90) among pregnancies as a result of the use of donor sperm as opposed to partner sperm. LIMITATIONS, REASONS FOR CAUTION: This study is retrospective and limited by the constraints of routinely collected data. No data were available for maternal characteristics such as BMI, smoking and partner age, which could all be potential confounders. Clustering of multiple pregnancies within women could not be accounted for as the data are reported only at the cycle level with no maternal identifiers. WIDER IMPLICATIONS OF THE FINDINGS: This study has demonstrated that there are no increased risks of adverse pregnancy outcome with donor sperm pregnancies. The reduction in miscarriage in pregnancies using donor sperm suggests that sperm could have a role in miscarriage, as the selection process for being accepted as donor is stringent. STUDY FUNDING/COMPETING INTEREST(S): No external funding was sought for this study. C.A. has received funding from Ferring to attend a UK meeting for trainees in reproductive Medicine. A.M. has received funding from Ferring, Cook, Merck Serono, Geodon Ritcher, and Pharmasure for speaking at, or attending, meetings relating to reproductive medicine. She has also participated in a Ferring advisory board. S.B. has received grants from Tenovus and the UK Medical Research Council. She has also been supported with a Medical Research Scotland PhD studentship. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Allen C, McLernon D, Bhattacharya S, et al. Early pregnancy outcomes of IVF cycles using donor versus partner sperm: analysis of 1 376 454 cycles recorded by the Human Fertilisation and Embryology Authority (1991-2016). Hum Reprod. 2023. PMID: 36961939. doi:10.1093/humrep/dead057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。